BiotechTube

ezetimibe

ApprovedCompleted
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Lipid Metabolism Disorder

Conditions

Lipid Metabolism Disorder

Trial Timeline

Sep 1, 2004 → Mar 1, 2005

NCT ID
NCT00651963

About ezetimibe

ezetimibe is a approved stage product being developed by Organon for Lipid Metabolism Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00651963. Target conditions include Lipid Metabolism Disorder.

What happened to similar drugs?

20 of 20 similar drugs in Lipid Metabolism Disorder were approved

Approved (20) Terminated (0) Active (0)
✅Pitavastatin + PravastatinEli LillyApproved
✅Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mgYuhanApproved
✅Diet+pravastatinDaiichi SankyoApproved
✅Bempedoic acid 180 mg tabletDaiichi SankyoApproved
✅Minute Maid Heart Wise orange juice + WelcholDaiichi SankyoApproved
✅Xuezhikang Capsule + Atorvastatin Calcium TabletsAstraZenecaApproved
✅rosuvastatin + placebo + rosuvastatin + atorvastatinAstraZenecaApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT01381679Pre-clinicalCompleted
NCT00704535Pre-clinicalCompleted
NCT00651963ApprovedCompleted

Competing Products

20 competing products in Lipid Metabolism Disorder

See all competitors
ProductCompanyStageHype Score
DRL-17822 or placeboDr. Reddy's LaboratoriesPhase 2
32
VK2809 + PlaceboViking TherapeuticsPhase 2
32
LY3202328 + Placebo + Atorvastatin + SimvastatinEli LillyPhase 1
29
Pitavastatin + PravastatinEli LillyApproved
43
RAY121Chugai PharmaceuticalPhase 1
36
RAY121Chugai PharmaceuticalPhase 1
36
Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mgYuhanApproved
43
YH14755 + Metformin + RosuvastatinYuhanPhase 3
40
YHR1705 + YHR1706 + YHR1705+YHR1706YuhanPhase 1
29
YHP1701 + YHR1703 + YHR1704YuhanPhase 3
40
YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placeboYuhanPhase 3
40
Moderate-intensity statin monotherapy + Ezetimibe or ezetimibe-statin combination therapyYuhanPre-clinical
33
Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDCYuhanPhase 1
29
Diet+pravastatinDaiichi SankyoApproved
43
MevalotinDaiichi SankyoPre-clinical
26
PravastatinDaiichi SankyoPre-clinical
26
Bempedoic acid 180 mg tabletDaiichi SankyoApproved
43
Minute Maid Heart Wise orange juice + WelcholDaiichi SankyoApproved
43
Pravafen + Pravastatin + FenofibrateShionogiPhase 3
40
LY3475766 - IV + LY3475766 - SC + Placebo - IV + Placebo - SCEli LillyPhase 1
29